|
US3740421A
(en)
|
1966-09-19 |
1973-06-19 |
Basf Wyandotte Corp |
Polyoxyethylene-polyoxypropylene aqueous gels
|
|
EP0027888B1
(en)
|
1979-09-21 |
1986-04-16 |
Hitachi, Ltd. |
Semiconductor switch
|
|
US4902506A
(en)
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
|
US4709017A
(en)
|
1985-06-07 |
1987-11-24 |
President And Fellows Of Harvard College |
Modified toxic vaccines
|
|
US4950740A
(en)
|
1987-03-17 |
1990-08-21 |
Cetus Corporation |
Recombinant diphtheria vaccines
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
ES2055785T3
(es)
|
1989-01-17 |
1994-09-01 |
Eniricerche Spa |
Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
FI920131A0
(fi)
|
1989-07-14 |
1992-01-13 |
Praxis Biolog Inc |
Cytokin- och hormonbaerare foer konjugatvaccin.
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
DE69113564T2
(de)
|
1990-08-13 |
1996-05-30 |
American Cyanamid Co |
Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
|
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
|
EP1958646A1
(en)
|
1992-02-11 |
2008-08-20 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
EP0643559B1
(en)
|
1992-05-06 |
1999-04-14 |
The President And Fellows Of Harvard College |
Diphtheria toxin receptor-binding region
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
ES2231770T3
(es)
|
1993-03-05 |
2005-05-16 |
Wyeth Holdings Corporation |
Nuevos plasmidos para la produccion de proteina crm y toxina difterica.
|
|
NZ274376A
(en)
|
1993-09-22 |
1997-11-24 |
Jackson H M Found Military Med |
Activating soluble carbohydrate using cyanylating reagents for the production of immunogenic constructs
|
|
US5917017A
(en)
|
1994-06-08 |
1999-06-29 |
President And Fellows Of Harvard College |
Diphtheria toxin vaccines bearing a mutated R domain
|
|
US6455673B1
(en)
|
1994-06-08 |
2002-09-24 |
President And Fellows Of Harvard College |
Multi-mutant diphtheria toxin vaccines
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
ES2200059T3
(es)
|
1995-03-22 |
2004-03-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Produccion de construcciones inmunogenicas usando carbohidratos solubles activados mediante reactivos cianilados organicos.
|
|
CA2196281A1
(en)
|
1995-06-06 |
1996-12-12 |
James J. Mond |
Dual carrier immunogenic construct
|
|
EP0942983B2
(en)
|
1996-10-31 |
2014-09-10 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae antigens and vaccines
|
|
KR19980067137A
(ko)
|
1997-01-31 |
1998-10-15 |
박원훈 |
알긴산염 초미세과립구를 이용한 폐렴구균 감연중에 대한 백신
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
|
IL145043A0
(en)
|
1999-03-19 |
2002-06-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
JP2002541808A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ， インコーポレイテッド |
ポリサッカリド結合体ワクチンのための組換えトキシンａタンパク質キャリア
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
EA006232B1
(ru)
|
2000-06-20 |
2005-10-27 |
Ай Ди Биомедикал Корпорейшн |
Стрептококковые антигены
|
|
HU227893B1
(en)
|
2000-06-29 |
2012-05-29 |
Glaxosmithkline Biolog Sa |
Vaccine compositions
|
|
IL155726A0
(en)
|
2000-12-28 |
2003-11-23 |
Wyeth Corp |
Recombinant protective protein from streptococcus pneumoniae
|
|
CA2444133A1
(en)
|
2001-04-16 |
2002-10-24 |
Wyeth Holdings Corporation |
Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
|
US20030035806A1
(en)
|
2001-05-11 |
2003-02-20 |
D'ambra Anello J. |
Novel meningitis conjugate vaccine
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
AU2002330681C1
(en)
|
2001-07-26 |
2015-04-02 |
Glaxosmithkline Biologicals S.A. |
Vaccines comprising aluminium adjuvants and histidine
|
|
GB0130215D0
(en)
|
2001-12-18 |
2002-02-06 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US7262024B2
(en)
|
2001-12-20 |
2007-08-28 |
Id Biomedical Corporation |
Streptococcus antigens
|
|
FR2850106B1
(fr)
|
2003-01-17 |
2005-02-25 |
Aventis Pasteur |
Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
|
|
EP1592440A4
(en)
|
2003-02-10 |
2007-07-11 |
Elan Pharm Inc |
IMMUNOGLOBULIN PREPARATION AND METHOD OF PRODUCING THE SAME
|
|
JP4597123B2
(ja)
|
2003-03-13 |
2010-12-15 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
細菌性細胞溶解素の精製方法
|
|
CA2519511A1
(en)
|
2003-03-17 |
2004-09-30 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
AU2003901717A0
(en)
|
2003-04-10 |
2003-05-01 |
Western Sydney Area Health Service |
Identification of streptococcus pneumoniae serotypes
|
|
DE102004017696A1
(de)
|
2004-04-10 |
2005-10-27 |
Vorwerk & Co. Interholding Gmbh |
Bodenpflegegerät mit einer rotierbaren Bürste
|
|
EP1781326A4
(en)
|
2004-06-04 |
2009-01-14 |
Pharmexa Inc |
INDUCTION OF AN IMMUNE RESPONSE AGAINST STREPTOCOKE PENUMONIA POLYSACCHARIDES
|
|
BRPI0519086A2
(pt)
|
2004-12-16 |
2008-12-23 |
Stichting Top |
bactÉria gram-positiva, nço invasiva, nço patogÊnica, vetor de dna, mÉtodo para a produÇço heteràloga de polissacarÍdeos capsulares complexos (cps) em uma bactÉria gram-positiva, nço invasiva, nço patogÊnica, e, composiÇço farmaceuticamente aceitÁvel
|
|
US7718791B2
(en)
|
2005-04-08 |
2010-05-18 |
Wyeth Llc |
Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation
|
|
CN102716480B
(zh)
*
|
2005-04-08 |
2023-03-21 |
惠氏有限责任公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物
|
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US7764278B2
(en)
|
2005-06-30 |
2010-07-27 |
Seiko Epson Corporation |
Integrated circuit device and electronic instrument
|
|
DK2384765T3
(en)
|
2005-12-22 |
2017-01-09 |
Glaxosmithkline Biologicals Sa |
Vaccine against Streptococcus pneumoniae.
|
|
DK1976974T3
(da)
|
2005-12-28 |
2014-09-15 |
Uab Research Foundation |
Pneumokok-serotyper.
|
|
JP5285431B2
(ja)
|
2005-12-28 |
2013-09-11 |
ザ ユーエイビー リサーチ ファウンデイション |
肺炎球菌血清型
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
|
EP3260134A1
(en)
|
2006-08-07 |
2017-12-27 |
President and Fellows of Harvard College |
Protein matrix vaccines and methods of making and administering such vaccines
|
|
MX2009003730A
(es)
|
2006-10-10 |
2009-04-22 |
Wyeth Corp |
Purificacion de polisacaridos de streptococcus pneumoniae tipo 3.
|
|
SI2436700T1
(sl)
|
2007-03-23 |
2018-09-28 |
Wyeth Llc |
Skrajšan postopek čiščenja za proizvodnjo kapsularnih polisaharidov streptococcusa pneumoniae
|
|
PL2167121T3
(pl)
|
2007-06-26 |
2016-01-29 |
Glaxosmithkline Biologicals Sa |
Szczepionka zawierająca koniugaty polisacharydu otoczkowego streptococcus pneumoniae
|
|
US8540955B2
(en)
|
2007-07-10 |
2013-09-24 |
Wyeth Llc |
Process for producing aluminum phosphate
|
|
US20100160622A1
(en)
|
2008-12-18 |
2010-06-24 |
Wyeth Llc |
Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon dioxide
|
|
BRPI0922981A8
(pt)
|
2008-12-18 |
2019-11-26 |
Wyeth Llc |
método para o controle do peso molecular polissacarídeo para o sorotipo 19a de streptococcus pneumoniae
|
|
CN101590224A
(zh)
|
2009-06-30 |
2009-12-02 |
广州精达医学科技有限公司 |
高效14价肺炎球菌结合疫苗
|
|
EP2473188A4
(en)
|
2009-09-09 |
2014-01-01 |
Matrivax Res & Dev Corp |
PROTEIN MATRIX VACCINES WITH IMPROVED IMMUNOGENICITY
|
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
|
TW201136603A
(en)
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
ES2614807T3
(es)
|
2010-06-04 |
2017-06-02 |
Wyeth Llc |
Formulaciones vacunales
|
|
CN103391714A
(zh)
|
2010-12-10 |
2013-11-13 |
默沙东公司 |
减轻搅动引起的免疫原性组合物聚集的新制剂
|
|
CN102068690A
(zh)
|
2010-12-31 |
2011-05-25 |
北京民海生物科技有限公司 |
多价肺炎球菌荚膜多糖结合疫苗及其制备方法
|
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
US9724401B2
(en)
|
2011-05-18 |
2017-08-08 |
Matrivax, Inc. |
Protein matrix vaccine compositions including polycations
|
|
CN103732610A
(zh)
|
2011-06-13 |
2014-04-16 |
默沙东公司 |
纯化天然或突变体形式的白喉毒素的方法
|
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
CN103623401A
(zh)
|
2012-08-23 |
2014-03-12 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
|
|
CN103656631B
(zh)
*
|
2012-09-24 |
2015-08-19 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白缀合物组合物及其制备方法
|
|
CN103656632B
(zh)
|
2012-09-24 |
2016-01-13 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖组合物、其制备方法及应用
|
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
FI3363806T3
(fi)
|
2012-12-20 |
2023-01-31 |
|
Glykokonjugaatiomenetelmä
|
|
ITMI20130142A1
(it)
|
2013-01-31 |
2014-08-01 |
Biosynth Srl |
Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
|
|
CN104069488A
(zh)
|
2013-03-29 |
2014-10-01 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
|
|
NZ721943A
(en)
|
2014-01-21 |
2022-07-01 |
Pfizer |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
RU2710393C2
(ru)
|
2014-01-21 |
2019-12-26 |
Пфайзер Инк. |
Способ получения иммуногенного конъюгата капсульный полисахарид Streptococcus pneumoniae-белок-носитель
|
|
US20160324949A1
(en)
|
2014-01-21 |
2016-11-10 |
Pfizer Inc. |
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
|
|
IL252915B2
(en)
|
2015-01-15 |
2024-04-01 |
Pfizer |
Immunogenic compositions for use in pneumococcal vaccines
|
|
KR102045663B1
(ko)
|
2015-05-04 |
2019-11-15 |
화이자 인코포레이티드 |
B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
|
|
PE20180460A1
(es)
|
2015-06-08 |
2018-03-06 |
Serum Inst Of India Private Ltd |
Metodos para mejorar la adsorcion de conjugados de polisacarido-proteina y una formulacion de vacuna multivalente obtenida con los mismos
|
|
EP3313436B1
(en)
|
2015-06-23 |
2020-12-23 |
Biological E Limited |
Multivalent pneumococcal conjugate vaccine
|
|
WO2017011338A1
(en)
|
2015-07-10 |
2017-01-19 |
President And Fellows Of Harvard College |
Sortase-mediated coupling of immunogenic polysaccharide-protein conjugates and their use
|
|
TWI756893B
(zh)
|
2015-07-21 |
2022-03-01 |
美商輝瑞股份有限公司 |
包含經共軛之莢膜糖抗原的致免疫性組成物、包含該致免疫性組成物之套組及彼等之用途
|
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US10947494B2
(en)
|
2015-11-17 |
2021-03-16 |
Pfizer Inc. |
Media and fermentation methods for producing polysaccharides in bacterial cell culture
|
|
JP6884145B2
(ja)
|
2015-11-20 |
2021-06-09 |
ファイザー・インク |
肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物
|
|
US11058757B2
(en)
|
2016-03-31 |
2021-07-13 |
Pogona, LLC |
Saccharide-polypeptide conjugate compositions and methods of use thereof
|
|
EP3474890A1
(en)
|
2016-06-22 |
2019-05-01 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften E. V. |
Pneumococcal polysaccharide-protein conjugate composition
|
|
CN105999254A
(zh)
|
2016-06-27 |
2016-10-12 |
北京智飞绿竹生物制药有限公司 |
含2型和12f血清型的15价肺炎球菌结合物组合疫苗
|
|
WO2018009906A1
(en)
|
2016-07-08 |
2018-01-11 |
President And Fellows Of Harvard College |
Whole cell-protein conjugates and methods of making the same
|
|
WO2018022573A1
(en)
|
2016-07-27 |
2018-02-01 |
Sharp Laboratories Of America, Inc. |
Wireless telecommuncations methods and apparatus using system information value tag
|
|
CN109862908B
(zh)
|
2016-08-05 |
2023-05-02 |
圣诺菲·帕斯图尔公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物
|
|
JP7001686B2
(ja)
|
2016-08-05 |
2022-02-04 |
サノフィ パスツール インコーポレイティッド |
多価肺炎球菌多糖体－タンパク質コンジュゲート組成物
|
|
TN2019000064A1
(en)
|
2016-09-06 |
2020-07-15 |
Lg Chemical Ltd |
Composition comprising multivalent capsular polysaccharide-transport protein and use thereof
|
|
EP3518965A1
(en)
|
2016-09-30 |
2019-08-07 |
Biological E Limited |
Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
|
|
KR20180043122A
(ko)
|
2016-10-19 |
2018-04-27 |
동국대학교 산학협력단 |
신규링커를 통한 폐렴구균 다당류-단백질 접합체 백신 및 이의 용도
|
|
WO2018080213A1
(ko)
|
2016-10-28 |
2018-05-03 |
주식회사 엘지화학 |
향상된 IgG 역가를 갖는 다가면역원성 조성물 및 이의 용도
|
|
CN108144056A
(zh)
|
2016-12-02 |
2018-06-12 |
武汉博沃生物科技有限公司 |
多价肺炎球菌多糖结合疫苗及其制备方法
|
|
AU2018208844B2
(en)
|
2017-01-20 |
2021-02-25 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
US20200222550A1
(en)
|
2017-01-31 |
2020-07-16 |
Merck Sharp & Dohme Corp. |
Methods for production of capsular polysaccharide protein conjugates from streptococcus pneumoniae serotype 19f
|
|
KR20190108583A
(ko)
|
2017-01-31 |
2019-09-24 |
머크 샤프 앤드 돔 코포레이션 |
다당류-단백질 접합체 제조 방법
|
|
WO2018156467A1
(en)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Methods for improving filterability of polysaccharide-protein conjugate reactions
|
|
US11219680B2
(en)
|
2017-02-24 |
2022-01-11 |
Merck Sharp & Dohme Corp. |
Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
|
|
CA3050120A1
(en)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates
|
|
US20200054740A1
(en)
|
2017-02-24 |
2020-02-20 |
Merck Sharp & Dohme Corp. |
Pneumococcal conjugate vaccine formulations
|
|
WO2018169303A1
(ko)
|
2017-03-15 |
2018-09-20 |
주식회사 엘지화학 |
다가 폐렴구균 백신 조성물
|
|
CN107929728A
(zh)
|
2017-04-19 |
2018-04-20 |
武汉博沃生物科技有限公司 |
一种肺炎球菌蛋白疫苗及其制备方法
|
|
KR20240018698A
(ko)
|
2017-06-10 |
2024-02-13 |
인벤트프라이즈 인크. |
면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
|
|
CN109091668A
(zh)
|
2017-06-20 |
2018-12-28 |
浙江博和瑞达生物科技有限公司 |
16价肺炎链球菌结合疫苗组合物
|
|
WO2019036313A1
(en)
|
2017-08-16 |
2019-02-21 |
Merck Sharp & Dohme Corp. |
CONJUGATED PNEUMOCOCCAL VACCINE FORMULATIONS
|
|
US11491216B2
(en)
|
2017-09-07 |
2022-11-08 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
|
BR112020004410A8
(pt)
|
2017-09-07 |
2023-01-31 |
Merck Sharp & Dohme |
Processos para a formulação de polissacarídeos pneumocócicos para conjugação a uma proteína carreadora
|
|
HUE068482T2
(hu)
|
2017-09-07 |
2025-01-28 |
Merck Sharp & Dohme Llc |
Pneumococcus-poliszacharidok és azok felhasználása immunogén poliszacharid-hordozóprotein konjugátumokban
|
|
CN111093649B
(zh)
|
2017-09-07 |
2023-08-25 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
|
CN111065387B
(zh)
|
2017-09-07 |
2023-08-25 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
|
WO2019070994A1
(en)
|
2017-10-04 |
2019-04-11 |
Liffey Biotech Limited |
SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
|
|
EP3700565A4
(en)
|
2017-10-25 |
2021-09-29 |
Merck Sharp & Dohme Corp. |
ADJUVED VACCINES
|
|
US11116828B2
(en)
*
|
2017-12-06 |
2021-09-14 |
Merck Sharp & Dohme Corp. |
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
JP2019118051A
(ja)
|
2017-12-27 |
2019-07-18 |
株式会社デンソー |
表示処理装置
|
|
CN108159408A
(zh)
|
2017-12-29 |
2018-06-15 |
云南沃森生物技术股份有限公司 |
一种多价肺炎球菌多糖-蛋白结合物组合物及其制备方法和应用
|
|
CN108245674A
(zh)
|
2018-01-18 |
2018-07-06 |
北京智飞绿竹生物制药有限公司 |
一种多价肺炎球菌结合物组合疫苗的处方及其制备方法
|
|
CN108079286B
(zh)
|
2018-01-19 |
2020-07-31 |
云南沃森生物技术股份有限公司 |
一种13价肺炎球菌多糖-蛋白结合物组合物及其制备方法和应用
|
|
IL276230B2
(en)
|
2018-02-05 |
2024-01-01 |
Sanofi Pasteur Inc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
KR102812816B1
(ko)
|
2018-02-05 |
2025-05-27 |
사노피 파스퇴르 인코포레이티드 |
다가 폐렴구균성 다당류-단백질 접합체 조성물
|
|
WO2019170068A1
(zh)
|
2018-03-05 |
2019-09-12 |
武汉博沃生物科技有限公司 |
一种肺炎链球菌疫苗及其制备方法
|
|
US11951162B2
(en)
|
2018-04-18 |
2024-04-09 |
Sk Bioscience Co., Ltd. |
Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
|
|
US20210252125A1
(en)
|
2018-04-30 |
2021-08-19 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
|
|
WO2019212842A1
(en)
|
2018-04-30 |
2019-11-07 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
|
|
US11896656B2
(en)
|
2018-04-30 |
2024-02-13 |
Merck Sharp & Dohme Llc |
Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
|
|
US20210236384A1
(en)
|
2018-05-07 |
2021-08-05 |
Meissner Filtration Products |
Lyophilization Bag
|
|
CN108339115B
(zh)
|
2018-05-11 |
2020-07-10 |
武汉博沃生物科技有限公司 |
使用重组载体蛋白的肺炎球菌联合疫苗及其制备方法
|
|
WO2019220304A1
(en)
|
2018-05-14 |
2019-11-21 |
Tergene Biotech Pvt. Ltd. |
15 valent pneumococcal polysaccharide conjugate vaccine
|
|
US20210223262A1
(en)
|
2018-06-07 |
2021-07-22 |
Merck Sharp & Dohme Corp. |
Lyosphere critical reagent kit
|
|
CN108524926B
(zh)
|
2018-06-29 |
2021-06-29 |
康希诺生物股份公司 |
一种多价肺炎球菌结合疫苗的制剂组合及其应用
|
|
WO2020009462A1
(ko)
|
2018-07-06 |
2020-01-09 |
주식회사 유바이오로직스 |
다가 폐렴구균 다당체-단백질 접합체를 포함하는 면역원성 조성물, 및 이를 포함하는 폐렴구균에 의한 질환 예방 백신
|
|
CN108543066A
(zh)
|
2018-07-17 |
2018-09-18 |
成都安特金生物技术有限公司 |
一种24价肺炎球菌多糖疫苗及其鉴别方法
|
|
WO2020021416A1
(en)
|
2018-07-21 |
2020-01-30 |
Biological E Limited |
Vaccine formulations comprising preservative system
|
|
US12048739B2
(en)
|
2018-09-23 |
2024-07-30 |
Biological E Limited |
Purified capsular polysaccharides of Streptococcus pneumoniae
|
|
BR112021012521A2
(pt)
|
2018-10-12 |
2021-09-14 |
Biological E Limited |
Vacina conjugada de polissacarídeo-proteína pneumocócica multivalente
|
|
CN109336989B
(zh)
|
2018-10-22 |
2022-05-13 |
北京智飞绿竹生物制药有限公司 |
一种通过粘度控制制备肺炎球菌荚膜多糖的方法
|
|
EP3893926A1
(en)
|
2018-12-12 |
2021-10-20 |
Pfizer Inc. |
Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
|
|
BR112021011961A8
(pt)
|
2018-12-19 |
2023-02-07 |
Merck Sharp & Dohme |
Composições compreendendo conjugados de polissacarídeo-proteína de streptococcus pneumoniae e métodos de uso dos mesmos
|
|
WO2020152706A1
(en)
|
2019-01-21 |
2020-07-30 |
Biological E Limited |
Multivalent pneumococcal conjugate vaccine compositions
|
|
WO2020157772A1
(en)
|
2019-01-28 |
2020-08-06 |
Biological E Limited |
Multivalent pneumococcal polysaccharide-protein conjugate vaccine compositions
|
|
CN109771640A
(zh)
|
2019-02-28 |
2019-05-21 |
北京智飞绿竹生物制药有限公司 |
多价肺炎球菌结合疫苗
|
|
CA3136278A1
(en)
|
2019-04-10 |
2020-10-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
MX2021014948A
(es)
|
2019-06-05 |
2022-01-24 |
Merck Sharp & Dohme Llc |
Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae.
|
|
CA3142692A1
(en)
|
2019-06-05 |
2020-12-10 |
Merck Sharp & Dohme Corp. |
An immunogenic serotype 35b pneumococcal polysaccharide-protein conjugate and conjugation process for making the same
|
|
CN110302375A
(zh)
|
2019-06-27 |
2019-10-08 |
康希诺生物股份公司 |
一种糖缀合物及其用途
|
|
CN110365663A
(zh)
*
|
2019-06-28 |
2019-10-22 |
北京淇瑀信息科技有限公司 |
一种隔离集群之间的访问方法、装置及电子设备
|
|
CN114364397B
(zh)
|
2019-07-18 |
2024-03-29 |
赛特瑞恩股份有限公司 |
含多价肺炎链球菌多糖-蛋白偶联物的免疫原性组合物、药物组合物及其用途
|
|
CN114728050A
(zh)
|
2019-07-31 |
2022-07-08 |
圣诺菲·帕斯图尔公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物及其使用方法
|
|
CN111821432B
(zh)
|
2020-08-05 |
2022-10-18 |
北京智飞绿竹生物制药有限公司 |
一种多价肺炎球菌结合疫苗
|